...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Association between promoter polymorphism (?108CT) of paraoxonase1 gene and it ' s paraoxonase activity in patients with Type2 diabetes in northern Iran
【24h】

Association between promoter polymorphism (?108CT) of paraoxonase1 gene and it ' s paraoxonase activity in patients with Type2 diabetes in northern Iran

机译:律师酮化酶1基因的启动子多态性(α108c& t)与伊朗北部Type2糖尿病患者的定律酶活性的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Type 2 diabetes mellitus (T2DM) is one of the diseases which depend on the obesity associated with insulin resistance. Various factors, such as a reduction in the activity of paraoxonase-1 enzyme (PON1), could affect T2DM. PON1 is a multifunctional enzyme with paraoxonase and arylesterase activities. The Activity of PON1 is influenced by various SNPs. The aim of presence study is to investigate the association between promoter polymorphism (?108C>T) of PON1 gene and its paraoxonase activity in patients suffering from Type 2 diabetes in Golestan Province, north of Iran. To this end, genomic DNA was extracted from whole blood then genotyping was carried out using PCR-RFLP and enzymatic activity of paraoxonase was measured in the serum of 90 healthy subjects and 90 diabetic patients. Data was analyzed using SPSS version 16. The relationship between the level of paraoxonase activity with polymorphisms of CC, CT, and TT was statistically significant in patients with T2DM. There was a significant association between polymorphism C-108>T of PON1 and type2 diabetes mellitus, with 24.4% of control group subjects and 15.5% of patients having CC genotype; p p p Highlights ? Paraoxonase activity of PON-1 decreases in patients with T2DM. ? There are three genotypes including CC, CT and TT in both control and patients with T2DM CT genotype was the most frequent genetype in both control and patients with T2DM TT is the most frequent genotype in patient with T2DM. ? TT genotype may reduce paraoxonase1enzymatic activity in patients with Type2 diabetes.
机译:摘要2型糖尿病(T2DM)是依赖于与胰岛素抵抗相关的肥胖症的疾病之一。各种因素,例如减少约束酶-1酶(PON1)的活性,可能影响T2DM。 PON1是具有亚氧基酶和芳酯酶活性的多功能酶。 PON1的活动受到各种SNP的影响。存在研究的目的是探讨PON1基因的启动子多态性(β108C> T)的关联及其在伊朗古古古古典型糖尿病患者的患者中的副氧酶活性。为此,从全血中提取基因组DNA,然后使用PCR-RFLP进行基因分型,并在90个健康受试者和90例糖尿病患者的血清中测量副氧酶的酶活性。使用SPSS版本16分析数据。在T2DM的患者中,CC,CT和TT多态性与多态性的定律酶活性水平之间的关系在患者中具有统计学意义。 PON1和Type2糖尿病多态性C-108> T之间存在显着关联,具有24.4%的对照组受试者和15.5%的患者患有CC基因型; p p p亮点? PON-1的律酶活性在T2DM患者中降低。还有三种基因型,包括CC,CT和TT,对照和T2DM CT基因型的患者是对照中最常见的基因型,并且T2DM TT的患者是T2DM患者中最常见的基因型。还TT基因型可减少2型糖尿病患者的律酶酶1酶活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号